Ionchannels and channelopaties in the heart. Viktória Szőts
|
|
- Bryce Oliver
- 5 years ago
- Views:
Transcription
1 Ionchannels and channelopaties in the heart Viktória Szőts
2 Action of membrane transport protein ATP-powered pump Ion chanels Transporters ions/s ions/s ions/s
3
4 Cardiac K + channels control the resting membrane potentials and the amplitude, duration, refractoriness and automaticity of action potentials. K + channels share a similar structure, composed by four pore-forming α-subunits assembled as tetramers or dimers forming K + selective pores and modulated by accessory subunits. The main K + channel pore forming protein is not translated from a single gene as Na + and Ca + channels, but is made up of four separate subunits, which assembly with ß-subunits to form the functional channel More than 80 different K + channels are expressed in the heart, display considerable diversity of native K + channels. Ca-independent transient outward potassium current (I to1 ) underlies by KCNA genes encoded Kv3.x and Kv4.x proteins. Delayed rectifier currents: the rapid (I Kr ) and slow (I Ks ) are encoded by different voltage-gated K+ channel genes. I Kr is produced by theαsubunit ERG (KCNH2), in co-assemblance with the ß-subunit MiRP1 (KCNE2). I Ks is produced by theα-subunit KvLQT1 (KCNQ) assembly with the accessories subunits of mink and MIPRs (KCNE1, KCNE2, KCNE3) Inward rectifier current (I K1 ) carried by Kir 2.1, Kir 2.2 and Kir 2.3 (KCNJ2, KCNJ12 and KCNJ4) channel proteins.
5 Molecular composition of the cardiac K-ionchannels Selectivity filter Nerbonne et al. Circ Res. 2001;89:
6 Membrane topology of the Kv and Kir2.x K-ionchannels Voltage gated K + channel Inward rectifier K + channel Kv channel CO 2 CO 2 CO 2 H5 H5
7 Kv complex MiRP N N α C C KChAP β PSD
8 Gating movi Ionchannels are open and close changing the permeability
9 Assembly of different ionchannel subunits Extracellular Intracellular Abott et al Neuropharm. 2004
10 Molecular assembly of ion channels Cavα Kvα Kir
11 Activation and Inactivation of The Sodium Channel Sodium channels are characterized by voltage-dependent activation, rapid inactivation, and selective ion conductance. Depolarization of the cell membrane opens the ion pore allowing sodium to passively enter the cell down its concentration gradient. The increase in sodium conductance further depolarizes the membrane to near the sodium equilibrium potential. Inactivation of the sodium channel occurs within milliseconds, initiating a brief refractory period during which the membrane is not excitable. The mechanism of inactivation has been modeled as a "hinged lid" or "ball and chain", where the intracellular loop connecting domains III and IV of the a subunit closes the pore and prevents passage of sodium ions.
12 Voltage-Gated Calcium Channels Voltage-gated calcium channels are heteromultimers composed of an α1 subunit and three auxiliary subunits, 2-δ, β and γ. The α1 subunit forms the ion pore and possesses gating functions and, in some cases, drug binding sites. Ten α1 subunits have been identified, which, in turn, are associated with the activities of the six classes of calcium channels. L-type channels have α1c (cardiac), α1d (neuronal/endocrine), α1s (skeletal muscle), and α1f (retinal) subunits; The α1 subunits each have four homologous domains (I-IV) that are composed of six transmembrane helices. The fourth transmembrane helix of each domain contains the voltage-sensing function. The four α1domains cluster in the membrane to form the ion pore. The β-subunit is localized intracellularly and is involved in the membrane trafficking of α1subunits. The γ-subunit is a glycoprotein having four transmembrane segments. The α2 subunit is a highly glycosylated extracellular protein that is attached to the membrane-spanning d-subunit by means of disulfide bonds. The α2-domain provides structural support required for channel stimulation, while the δ domain modulates the voltage-dependent activation and steady-state inactivation of the channel.
13 Ionic currents and ion transporters responsible for cardiac action potential Abriel H. et al., Swiss Med Wkly 2004, w. ch
14 The expression and properties of these K+ channels are altered in cardiac diseases (ie. cardiac arrhythmia, Long QT syndrome, hypertrophyc cardiomyopathy, Andersen syndrome, heart failure). These K+ channels still require further investigation because they are involved in the basic normal heart rhythm, and may be altered in cardiac diseases.
15 Proposed cellular mechanism for the development of Torsade de pointes in the long QT syndrome
16 Prolonged QT interval on ECG (reflects prolonged APD) APD governed by a delicate balance between inward (Na + or Ca + ) and outward (K + ) ionic current Affecting the Na + or Ca + channel prolong APD via gain-offfunction mechanism, while mutation in genes encoding K + channel by loss-off-function mechanism
17 Risk factors for developing Torsade de pointes Genetic variants (polymorphysm or mutations) Abriel H. et al., Swiss Med Wkly 2004,
18 Ionic current, proteins and genes associated with inherited arrhythmias Napolitano et al. Pharm. & ther. 2006,110:1-13
19 Congenital and aquired forms of long QT syndromes Abriel H. et al., Swiss Med Wkly 2004, w. ch
20 K+, Na+ channel LQT-associated genes and proteins Current Genes Disease I To1 I Ks I Kr I Na I k1 I kur I kach I katp I CaL Kv4.3 KvLQT1(KCNQ1) Mink (KCNE1) HERG (KCNH2) MiRP1 (KCNE2) SCN5A Kir2.1 (KCNJ2) Kv1.7(KCNA7),Kv1.5 Kir3.4 Kir6.2 Cav1.2 (CACNA1c) LQT LQT1, JLN1 LQT5, JLN2 LQT2 LQT6, FAF LQT3 Brugada Syndrome, Cardiac conduction defect, Sick sinus syndrome LQT7 Andersen-Tawil Syndrome Progressziv familial heart Block1 AF LQT8 Timothy Syndrome
21
22 Gene mutations in LQT1 and LQT2 HERG KCNH2 KvLQT1 KCNQ1 LQT2 LQT1
23
24 Molecular structure and the membrane topology of the HERG channel Mutations in HERG channel
25 Atrial fibrillation (AF): Rapid shortening of the AERP Functional changes of ion channel Reduction of I CaL and gene expression of L-type Ca channel Increase in K+-ion channel activity of I kach, I k1 Reduction in I to and I sus Reduced gene expression in Kv1.5, Kv4.3, Kir3.1, Kir3.4, Kir6.2
26 Pivotal role of Ser phosphorilation as a regulatory mechanism in Cav1.2 mode1/mode2 gating. Timothy s syndrome
27 Current Genes Disease I Kr I K1 I Ks HERG (KCNH2) Kir2.x (KCNJ2) KvLQT1(KCNQ1) ShortQT I Ca CASQ2 CPVT catecholamine-induced (Calsequestrin2) polymorphic CPVT ventricular tachycardia I Ca RyR2 CPVT I kach β 1 -adrenoceptor (β 1 -AR) β 2 -adrenoceptor (β 2 -AR) Kv3.1, Kv3.4 Risk factor, modify disease or influence progression of disease Risk factor, modify disease or influence progression of disease AF
28 Complexity of protein-protein interaction in cardiomyocytes
29 Missense mutation in calsequestrin2 (CASQ2) wild type Syncope Seizures or Sudden death In response to Physical activity or Emotional stress mutant Associated with autosomal recessive catecholamineinduced polymorphic ventricular tachycardia (CPVT)
30 Kir2.1 ionchannel has an autosomal dominant mutation in Andersen-Tawil Syndrome Cardiac arrhytmias Periodic paralysis Dysmorphic bone structure(scoliosis, low-set ears, small chin, broad forehead
31 Facial and sceletal features in Andersen- Tawil syndrome
32 Kir2.1 ion channel mutation GIRK mutation
33 ANP role
34 Gene-specific mutation study Genexpression study Microarray, qrt-pcr Proteomica
35 Kir2.x analysis by RT-PCR kir2.x mrna in dog & human Kir2.1 Kir2.2 Kir2.3 Kir2.4 HUMAN DOG
36 Expression of Kv1.5 protein in human and dog kda RV LV RA LA RV LV DOG HUMAN 6 RA LA Relative amount of Kv HUMAN DOG n=12 n= 6 LV LA
37 Co-localization of Kvβ β2 auxillary subunit with Kv1.5 in dog left ventricular myocytes Kv1.5-FITC Kvβ β2-texas red 100 µ Kv1.5-FITC Kvβ β2-texas red
38
Ionchannels and channelopaties in the heart
Ionchannels and channelopaties in the heart Csatorna müködés Több betegség Drugok kapcsolodása csat.hoz Sejtekbe ioncsat.expresszios módszerek, bemutatása Viktória Szőts Action of membrane transport protein
More informationGene annotation for heart rhythm. 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5.
Gene annotation for heart rhythm 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5. EC coupling Control of heart rate Autonomic regulation of heart function
More informationGenetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.
Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per
More informationStrength and weakness of genetic testing in clinical routine.
Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular
More informationBasics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD
Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD University of Pittsburgh Medical Center Pittsburgh, PA International Symposium of Inherited Arrhythmia Disorders and Hypertrophic
More informationGenetic testing in Cardiomyopathies
Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione
More informationMolecular Physiology of Ion Channels That Control Cardiac Repolarization
Chapter 2 / Ion Channels Underlying Repolarization 13 2 Molecular Physiology of Ion Channels That Control Cardiac Repolarization Jeanne M. Nerbonne, PhD and Robert S. Kass, PhD CONTENTS INTRODUCTION INWARD
More informationGenetic Testing for Cardiac Ion Channelopathies
Genetic Testing for Cardiac Ion Channelopathies Policy Number: 2.04.43 Last Review: 11/2018 Origination: 6/2007 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationRhythm and Blues Drugs and QT Prolongation
Rhythm and Blues Drugs and QT Prolongation Dr Martin Quinn St Vincents University Hospital Irish Medication Safety Network conference Farmleigh 18 Oct 2013 Drugs and QT Prolongation Anti-psychotic, antidepressant,
More informationProlonged QT Syndromes: Congenital and Acquired
Prolonged QT Syndromes: Congenital and Acquired April 30, 2014 Elizabeth S. Kaufman, MD I have no financial disclosures. MetroHealth Campus, Case Western Reserve University Prolonged QT Syndromes Congenital
More informationDifferences in cardiac atrial and ventricular ion channels
Differences in cardiac atrial and ventricular ion channels Norbert Jost, PhD Department of Pharmacology & Pharmacotherapy, University of Szeged Division for Cardiovascular Pharmacology, Hungarian Academy
More informationPreventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete
Preventing Sudden Death in Young Athletes Ronn E. Tanel, MD Director, Pediatric Arrhythmia Service UCSF Children s Hospital Associate Professor of Pediatrics UCSF School of Medicine Outline Sudden death
More informationName of Presenter: Marwan Refaat, MD
NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have no actual or potential conflict of interest in relation
More informationThe Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes
The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes RHEA C. PIMENTEL, MD, FACC, FHRS UNIVERSITY OF KANSAS HOSPITAL MID AMERICA CARDIOLOGY AUGUST 19, 2012 Monogenic Arrhythmia Syndromes Mendelian
More informationSEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !
Sudden cardiac death in the adult Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel.! " # $ % Cancers National Vital Statistics Report, Vol 49 (11), Oct. 12, 2001. 20% 25% State-specific
More informationCurriculum vitae Balázs Ördög
Curriculum vitae Balázs Ördög 1997 2002: Szent István Univ. M.Sc., Engineer of agriculture (biotechnology) 2007 2012: Montreal Heart Institue, postdoc 2002 2007: Univ. Szeged, Dept. Medical Biology, Ph.D.
More informationDescription. Page: 1 of 31. Genetic Testing for Cardiac Ion Channelopathies. Last Review Status/Date: December 2015
Genetic Testing for Cardiac Ion Last Review Status/Date: December 2015 Genetic Testing for Cardiac Ion Description Page: 1 of 31 Genetic testing is available for patients suspected of having cardiac ion
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Genetic Testing for Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Genetic Testing for Professional Institutional Original Effective Date: August 12,
More informationMolecular and genetic basis of sudden cardiac death
Molecular and genetic basis of sudden cardiac death Alfred L. George Jr. J Clin Invest. 2013;123(1):75-83. https://doi.org/10.1172/jci62928. Review Series The abrupt cessation of effective cardiac function
More informationIs There a Genomic Basis to Acquired Channelopathic disease
Is There a Genomic Basis to Acquired Channelopathic disease Yaniv Bar-Cohen, M.D. Associate Professor of Pediatrics Division of Cardiology / Electrophysiology Children s Hospital Los Angeles Keck School
More informationGenetic Testing for Cardiac Ion Channelopathies. Description
Genetic Testing for Cardiac Ion Page: 1 of 30 Last Review Status/Date: March 2017 Genetic Testing for Cardiac Ion Description Genetic testing is available for patients suspected of having cardiac ion channelopathies
More informationSudden Unexplained Death in Epilepsy (SUDEP) and Dravet Syndrome
2016 DSF Biennial Family and Professional Conference Coral Gables, FL June 23-26, 2016 Sudden Unexplained Death in Epilepsy (SUDEP) and Dravet Syndrome Ronald J. Kanter, MD Director, Cardiac Electrophysiology,
More informationCONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT.
CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT. SAHA Annual Congress 2017. Samkelo Jiyana, Adele Greyling, Andile Nxele, ZM,Makrexeni,L.Pepeta. BACKGROUND
More informationProtocol. Genetic Testing for Cardiac Ion Channelopathies
Protocol Genetic Testing for Cardiac Ion Channelopathies (20443) Medical Benefit Effective Date: 04/0/8 Next Review Date: /8 Preauthorization Yes Review Dates: 05/09, 05/0, 03/, 03/2, 03/3, 03/4, 03/5,
More informationPhenotypic Manifestations of Mutations in Genes Encoding Subunits of Cardiac Potassium Channels
This Review is the last in a thematic series on Inherited Arrhythmogenic Syndromes: The Molecular Revolution, which includes the following articles: The Fifteen Years that Shaped Molecular Electrophysiology:
More informationCase studies in Channelopathies
Case studies in Channelopathies FABRICE CHOUTY, MD MEDICAL DIRECTOR HANNOVER-LIFE RE, PARIS (F) INTRODUCTION Thanks to the invasive electrophysiology and the progress of imaging techniques as well as the
More informationNormal heart rhythm requires the finely orchestrated
Basic Science for Clinicians Molecular Basis of Arrhythmias Manish Shah, MD; Fadi G. Akar, PhD; Gordon F. Tomaselli, MD Abstract The characterization of single gene disorders has provided important insights
More informationSudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
Magi et al. Journal of Biomedical Science (2017) 24:56 DOI 10.1186/s12929-017-0364-6 REVIEW Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies Simona Magi 1*, Vincenzo
More informationThe action potential and the underlying ionic currents. Norbert Jost, PhD
The action potential and the underlying ionic currents Norbert Jost, PhD The propagation of the stimulation in the heart Sinus node Left atria His Bundle Conduction velocity in m/s Time to arrive from
More informationWhat is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer
What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment Andreas Pflaumer Diagnosis of CPVT Induction of different types of VES or VT by exercise or catecholamines AND exclusion of of other
More informationMechanism of Action of the Antiarrhythmic Agent AZD7009
Department of Medical Biophysics Institute of Neuroscience and Physiology Göteborg University Mechanism of Action of the Antiarrhythmic Agent AZD7009 Frida Persson Göteborg 2007 ISBN 978-91-628-7047-8
More informationWojciech Szczepański, MD, PhD Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division Medical University of Bialystok
Channelopathies: - Long QT syndrome - Short QT syndrome - Brugada syndrome - Early repolarization syndrome - Catecholaminergic polymorphic ventricular tachycardia Wojciech Szczepański, MD, PhD Department
More informationGenetic Basis of Ventricular Arrhythmias
Genetic Basis of Ventricular Arrhythmias Tim Boussy, MD a, *, Gaetano Paparella, MD a, Carlo de Asmundis, MD a, Andrea Sarkozy, MD a, Gian Battista Chierchia, MD a, Josep Brugada, MD, PhD b, Ramon Brugada,
More informationLong QT. Long QT Syndrome. A Guide for Patients
Long QT Long QT Syndrome A Guide for Patients Long QT Syndrome What is long QT syndrome? Long QT syndrome (LQTS) is a condition that affects the ability of the heart to beat (contract) regularly and efficiently.
More informationPhenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Sodium Channel
This Review is part of a thematic series on Inherited Arrhythmogenic Syndromes: The Molecular Revolution, which includes the following articles: The Fifteen Years That Shaped Molecular Electrophysiology:
More informationTdP Mechanisms and CiPA
TdP Mechanisms and CiPA Craig T. January, MD, PhD Division of Cardiovascular Medicine University of Wisconsin-Madison Cardiac Safety Research Consortium Hilton Washington DC December 6, 2016 Disclosures
More informationCardiac arrhythmias are associated with high morbidity
Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies Pietro Enea Lazzerini, MD; Pier Leopoldo Capecchi, MD;* Nabil El-Sherif, MD;* Franco Laghi-Pasini, MD;* Mohamed Boutjdir,
More informationInherited Arrhythmia Syndromes
Inherited Arrhythmia Syndromes When to perform Genetic testing? Arthur AM Wilde February 4, 2017 Which pts should undergo genetic testing? SCD victims with a likely diagnosis Pts diagnosed with an inherited
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Cardiac Ion Channelopathies File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_cardiac_ion_channelopathies 10/2008 4/2018
More informationDeposited on: 29 October 2009
Workman, A.J. (2009) Mechanisms of postcardiac surgery atrial fibrillation: more pieces in a difficult puzzle. Heart Rhythm, 6 (10). pp. 1423-1424. ISSN 1547-5271 http://eprints.gla.ac.uk/7847/ Deposited
More informationAntiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2017
Antiarrhythmic Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2017 Types of Cardiac Arrhythmias Abnormalities of Impulse Formation: Rate disturbances. Triggered
More informationAntiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
Antiarrhythmic Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 2 Ion Permeability Changes Potential Changes Genes and Proteins 3 Cardiac Na+ channels 5 6
More informationGenomics and Cardiac Arrhythmias
Journal of the American College of Cardiology Vol. 47, No. 1, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.08.059
More informationJ Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University
J Wave Syndromes Osama Diab Lecturer of Cardiology Ain Shams University J Wave Syndromes Group of electric disorders characterized by > 1 mm elevation of the J point or prominent J wave with or without
More informationPearls of the ESC/ERS Guidelines 2015 Channelopathies
Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias
More informationSection: Effective Date: Subsection: Original Policy Date: Subject: Page: Last Review Status/Date: Background
Genetic Testing for Cardiac Ion Last Review Status/Date: March 2014 Genetic Testing for Cardiac Ion Description Page: 1 of 22 Genetic testing is available for patients suspected of having cardiac ion channelopathies
More informationReview. The Genetics of Cardiac Disease Associated with Sudden Cardiac Death
ASIP 2012 JMD CME Program Review The Journal of Molecular Diagnostics, Vol. 14, No. 5, September 2012 Copyright 2012 American Society for Investigative Pathology and the Association for Molecular Pathology.
More informationHereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases
Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle
More informationIon channel dysfunction and diseases of the heart
Basisvorlesung (BVO) Zelluläre Signaltransduktion- Krankheitsbilder Sommersemester 2015 902.384 PhD- Programm Molecular Signal Transduction Ion channel dysfunction and diseases of the heart H. Todt Dpt.
More informationPatient Resources: Cardiac Channelopathies
Patient Resources: Cardiac Channelopathies Overview of Cardiac Channelopathies: CPVT, Long QT Syndrome and Brugada Syndrome Heart muscle cells contract because of movement of certain molecules (called
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Genetic Testing for Page 1 of 23 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Genetic Testing for Professional Institutional Original Effective Date: August
More informationREVIEW ARTICLES Long QT syndrome and anaesthesia
British Journal of Anaesthesia 90 (3): 349±66 (2003) DOI: 10.1093/bja/aeg061 REVIEW ARTICLES Long QT syndrome and anaesthesia P. D. Booker*, S. D. Whyte and E. J. Ladusans Cardiac Unit, Royal Liverpool
More informationGenetic Testing for Cardiac Ion Channelopathies
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationWINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY
Learning Objectives to Disclose: To CRITIQUE the ICD and its role in the treatment of BrS, CPVT, and LQTS WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY Conflicts of Interest to Disclose: Consultant
More informationLocal Anesthetics. Xiaoping Du Room E417 MSB Department of Pharmacology Phone (312) ;
Local Anesthetics Xiaoping Du Room E417 MSB Department of Pharmacology Phone (312)355 0237; Email: xdu@uic.edu Summary: Local anesthetics are drugs used to prevent or relieve pain in the specific regions
More informationCARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA
CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA Nicole Schmitt, Morten Grunnet, and Søren-Peter Olesen Physiol Rev 94: 609 653, 2014 doi:10.1152/physrev.00022.2013 The Danish
More informationMechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS)
Mechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS) Craig T. January, MD, PhD Division of Cardiovascular Medicine University of Wisconsin-Madison CSRC-HESI-FDA Rechanneling the Current Cardiac
More informationThe long QT syndrome family of cardiac ion channelopathies: A HuGE review* Stephen M. Modell, MD, MS 1, and Michael H.
March 2006 Vol. 8 No. 3 review The long QT syndrome family of cardiac ion channelopathies: A HuGE review* Stephen M. Modell, MD, MS 1, and Michael H. Lehmann, MD 2 Long QT syndrome (LQTS) refers to a group
More informationThe Genetics and Prevention of Sudden Cardiac Death
The Genetics and Prevention of Sudden Cardiac Death Sudden cardiac death (SCD), a serious public health problem Every day, between 1,600 and 2,000 people die worldwide from genetically caused SCD. 1 SCD
More informationAtrial fibrillation in Cardiac Channelopathies
Atrial fibrillation in Cardiac Channelopathies Thejus, Jayachandran Francis, Johnson Introduction Atrial fibrillation is the commonest arrhythmia encountered in day-to-day clinical practice. Its prevalence
More informationBear: Neuroscience: Exploring the Brain 3e
Bear: Neuroscience: Exploring the Brain 3e Chapter 03: The Neuronal Membrane at Rest Introduction Action potential in the nervous system Action potential vs. resting potential Slide 1 Slide 2 Cytosolic
More informationCardiovascular diseases
Cardiovascular diseases Slide1. The heart s task and work: During a life span, the heart works without resting as a double muscle pump with its regulated rhythm. On right side to refresh the blood with
More informationLa corrente tardiva del Na come nuovo target di terapia antiischemica: ruolo della ranolazina
1 La corrente tardiva del Na come nuovo target di terapia antiischemica: ruolo della ranolazina Alessandro Mugelli* Department of Preclinical and Clinical Pharmacology University of Florence Florence (Italy)
More informationUvA-DARE (Digital Academic Repository) Cardiac sodium channelopathies Amin, A.S.; Asghari-Roodsari, A.; Tan, H.L. Published in: Plügers Archiv
UvA-DARE (Digital Academic Repository) Cardiac sodium channelopathies Amin, A.S.; Asghari-Roodsari, A.; Tan, H.L. Published in: Plügers Archiv DOI: 10.1007/s00424-009-0761-0 Link to publication Citation
More informationICD in a young patient with syncope
ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy
More informationPharmacogenomics of Drug-Induced Conditions
Pharmacogenomics of Drug-Induced Conditions Dan M. Roden, M.D. Professor of Medicine and Pharmacology Director, Oates Institute for Experimental Therapeutics Assistant Vice-Chancellor for Personalized
More informationSilvia G Priori MD PhD
Novel therapies for the long QT syndrome. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri Pavia, Italy and Leon Charney Division of Cardiology, Cardiovascular Genetics Program,
More informationRole of potassium currents in cardiac arrhythmias
Europace (2008) 10, 1133 1137 doi:10.1093/europace/eun193 REVIEW Role of potassium currents in cardiac arrhythmias Ursula Ravens 1 * and Elisabetta Cerbai 2 1 Department of Pharmacology and Toxicology,
More information3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives
NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss
More informationIn Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative
In Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative Gary Gintant, AbbVie for the Comprehensive in Vitro ProArrhythmia Assay Group Hot
More informationCardiology Genetics Report Long QT Syndrome (LQTS) Panel
Patient Name: Test(s) Requested: The ordered test and the genes analyzed are Genes Evaluated (Disease): Result: Only mutations detected appear here KCNQ1 (LQT1 and Jervell and LangeNielsen syndrome), KCNH2
More informationVoltage Gated Ion Channels
Voltage Gated Ion Channels The Machines That Make It Possible... Topics I Introduction Electrochemical Gradients Passive Membrane Properties Action Potential Voltage-Gated Ion Channels Ligand-Gated Ion
More informationModeling of Anatomy, Electrophysiology and Tension Development in the Human Heart
European Functional Cardiac Modeling Meeting Modeling of Anatomy, Electrophysiology and Tension Development in the Human Heart Dr.-Ing. Gunnar Seemann Overview Electrophysiology Tension development Anatomy
More informationJaigurumajaigurumajaiguruma. Autonomic Modulation of Ventricular Repolarization in Long QT syndrome. Dr. Rajkumar Mantravadi MBBS 1994 MRCP (UK) 2002
-+-jaigurumajaigurumajaiguruma Jaigurumajaigurumajaiguruma Autonomic Modulation of Ventricular Repolarization in Long QT syndrome by Dr. Rajkumar Mantravadi MBBS 1994 MRCP (UK) 2002 Submitted to the Department
More informationAntiarrhythmic Drugs
Antiarrhythmic Drugs DR ATIF ALQUBBANY A S S I S T A N T P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y C O N S U L T A N T C A R D I O L O G Y & I N T E R V E N T I O N A L E P A C H D /
More informationThe Self-Assessment Approach
Comprehensively updated and significantly expanded to include the latest recommendations, findings from leading-edge research, emergent diagnostic tools, and new therapeutic options, Essential Cardiac
More informationPharmacology of cardiac potassium channels
Cardiovascular Research 62 (2004) 9 33 Review Pharmacology of cardiac potassium channels Juan Tamargo*, Ricardo Caballero, Ricardo Gómez, Carmen Valenzuela, Eva Delpón Department of Pharmacology, School
More informationArrhythmias (II) Ventricular Arrhythmias. Disclosures
Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi
More informationDrugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification
Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification Class I Na Channel Blockers Flecainide Propafenone Class III K channel Blockers Dofetilide,
More informationCellular Neurobiology BIPN140. 1st Midterm Exam October 18 th, Tuesday Material covered: Lectures 1-6 & Reading
Cellular Neurobiology BIPN140 1st Midterm Exam October 18 th, Tuesday Material covered: Lectures 1-6 & Reading Review session October 17 th 3500 Pacitic Hall, 6-8 pm (access code is 127895) Come with questions!
More informationFANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers)
Clinical Features FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers) History Syncope or presyncope compatible with ventricular tachyarrhythmia, especially relating to
More informationIntroduction. Circulation
Introduction Circulation 1- Systemic (general) circulation 2- Pulmonary circulation carries oxygenated blood to all parts of the body carries deoxygenated blood to the lungs From Lt. ventricle aorta From
More informationTABLE 1. Mutations in the Cardiac Ryanodine Receptor Gene (RyR2) Associated With CPVT and ARVD2* Amino acid Nucleotide Disease Families Familial? Doma
EDITORIAL Sudden Unexplained Death Caused by Cardiac Ryanodine Receptor (RyR2) Mutations About 10% to 20% of postmortem examinations of young people who were apparently healthy but died suddenly and unexpectedly
More informationEtude de Maladies du Rythme Cardiaque à l'aide de Cellules Souches Pluripotentes Induites
UNIVERSITÉ DE NANTES FACULTÉ DE MÉDECINE -------- ÉCOLE DOCTORALE BIOLOGIE-SANTÉ Année 2015 N attribué par la bibliothèque Etude de Maladies du Rythme Cardiaque à l'aide de Cellules Souches Pluripotentes
More informationChapter 12: Cardiovascular Physiology System Overview
Chapter 12: Cardiovascular Physiology System Overview Components of the cardiovascular system: Heart Vascular system Blood Figure 12-1 Plasma includes water, ions, proteins, nutrients, hormones, wastes,
More informationDefining new insight into fatal human arrhythmia: a mathematical analysis
University of Iowa Iowa Research Online Theses and Dissertations Spring 2012 Defining new insight into fatal human arrhythmia: a mathematical analysis Roseanne Marie Wolf University of Iowa Copyright 2012
More informationAbout OMICS Group Conferences
About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of
More informationLong Q. Long QT Syndrome. A Guide for
Long Q Long QT Syndrome A Guide for Introduction Long QT syndrome (LQTS) is a genetic heart disorder due to the malfunction of cardiac ion channels that results in 4,000 deaths annually in the United States
More informationPotassium Channelopathies: Consequences and Impact on Treatment December 4, 2010
Potassium Channelopathies: Consequences and Impact on Treatment December 4, 2010 Karen S. Wilcox, Ph.D. Department of Pharmacology & Toxicology Anticonvulsant Drug Development Program University of Utah
More informationThe Genetic Basis for Cardiac Dysrhythmias and the Long QT Syndrome
Ovid Technologies, Inc. Email Service ------------------------------ Results: The Journal of Cardiovascular Nursing Issue: Volume 13(4), July 1999, pp 34-45 Copyright: (C) 1999 Aspen Publishers, Inc. Publication
More informationSudden cardiac death (SCD) accounts for 20% of mortality. Sudden Cardiac Death Compendium. Genetics of Sudden Cardiac Death
Sudden Cardiac Death Compendium Circulation Research Compendium on Sudden Cardiac Death The Spectrum of Epidemiology Underlying Sudden Cardiac Death Sudden Cardiac Death Risk Stratification Genetics of
More informationLong QT syndrome a genetic cardiac channelopathy
Artykuł poglądowy/review article Long QT syndrome a genetic cardiac channelopathy Kardiologia Polska 2010; 68, 5: 575 583 Copyright Via Medica ISSN 0022 9032 Zespół długiego QT genetycznie uwarunkowana
More information1 Ions, Channels, and Currents
1 Ions, Channels, and Currents Self-Assessment Questions 1.1 POTASSIUM CHANNELS AND CURRENTS 1 In a diagram of APshown below, which one of the following currents is active where arrow is pointing? A I
More informationHereditary Conditions Predisposing to Sudden Death
Hereditary Conditions Predisposing to Sudden Death Barry London, MD PhD University of Pittsburgh Medical Center Pittsburgh, PA SCAA/HRS/UPMC Symposium Managing the Patient at Risk for Sudden Death 10/08/10
More informationΠαναγιώτης Ιωαννίδης. Διευθυντής Τμήματος Αρρυθμιών & Επεμβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών
Διαστρωμάτωση κινδύνου για αιφνίδιο καρδιακό θάνατο σε ασθενείς που δεν συμπεριλαμβάνονται σε μεγάλες κλινικές μελέτες «Ασθενείς με ηλεκτρικά νοσήματα» Παναγιώτης Ιωαννίδης Διευθυντής Τμήματος Αρρυθμιών
More informationTransport through biological membranes. Christine Carrington Biochemistry Unit Apr 2010
Transport through biological membranes Christine Carrington Biochemistry Unit Apr 2010 Biological membranes Membranes control the structures and environments of the compartments they define and thereby
More informationChapter 3 subtitles Action potentials
CELLULAR NEUROPHYSIOLOGY CONSTANCE HAMMOND Chapter 3 subtitles Action potentials Introduction (3:15) This third chapter explains the calcium current triggered by the arrival of the action potential in
More informationCase Demonstrations in Congenital and Acquired Long QT Syndrome
Case Demonstrations in Congenital and Acquired Long QT Syndrome Can You Make A Correct ECG Interpretation? Li Zhang, MD; 1-2 G. Michael Vincent, MD 1 1. LQTS Studies, Department t of Medicine i LDS Hospital,
More information1. (1 pt) At the equilibrium potential of an ion, what two things are equal? Electrical potential (voltage) and chemical potential (concentration)
MIDERM REVIEW QUESIONS: IO 3411 (hese are questions from 3 of the previous years midterms) 1. (1 pt) t the equilibrium potential of an ion, what two things are equal? Electrical potential (voltage) and
More informationChannelopathies. Review article Korean J Pediatr 2014;57(1):1-18. Introduction
Review article Korean J Pediatr 2014;57(1):1-18 pissn 1738-1061 eissn 2092-7258 Korean J Pediatr Channelopathies June-Bum Kim, MD, PhD Department of Pediatrics, Seoul Children s Hospital, Seoul, Korea
More information